Interleukin 10 Blocks HIV Replication in Macrophages by Inhibiting the Autocrine Loop of Tumor Necrosis Factor α and Interleukin 6 Induction of Virus

AIDS Research and Human Retroviruses

Volumn 10, Issue 10, 1994, Pages 1199-1206

  Weissman, Drew ^a   Poli, Guido ^a,b   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; RNA DIRECTED DNA POLYMERASE; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

ANTIVIRAL AGENTS; B-LYMPHOCYTES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT ANTIBODY TECHNIQUE; HIV; HIV INFECTIONS; HUMAN; INTERLEUKIN-10; INTERLEUKIN-6; KINETICS; MACROPHAGES; MONOCYTES; T-LYMPHOCYTES; TIME FACTORS; TUMOR NECROSIS FACTOR; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0028100057     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.1994.10.1199     Document Type: Article

References (47)

1. + T cell clones and peripheral blood T cells. I Immunol 1992; 149: 2378–2384.
2. Vieira P., de Waal-Malefyt R., Dang MN., Johnson KE., Kastelein R., Fiorentino DF., deVries IE., Roncarolo MG., Mosmann TR., and Moore KW.: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI. Proc Nati Acad Sei USA 1991; 88: 1172–1176.
3. Enk AH. and Katz SI.: Identification and induction of keratinocytederived IL-10.1 Immunol 1992; 149: 92–95.
4. Rivas IM. and Ullrich SE.: Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. I Immunol 1992; 149: 3865–3871.
5. Del Prete G., de Carli M., Almerigogna F., Giudizi MG., Biagiotti R., and Romagnani S.: Human IL-10 is produced by both type 1 helper (Th 1 ) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. I Immunol 1993; 150: 353–360.
6. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. I Immunol 1993; 150: 4754–4765.
7. Taga K. and Tosato G.: IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992; 148: 1143–1148.
8. Taga K., Mostowski H., and Tosato G.: Human interleukin-10 can directly inhibit T-cell growth. Blood 1993; 81: 2964–2971.
9. + T lymphocyte migration. I Immunol 1993; 151: 4545–4551.
10. Chen WF. and Zlotnik A.: IL-10: A novel cytotoxic T cell differentiation factor. J Immunol 1991; 147: 528–534.
11. de Waal Malefyt R., Haanen I., Spits H., Roncarolo MG., te Velde AA., Figdor C., Johnson K., Kastelein R., Yssel H., and de Vries IE.: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. I Exp Med 1991; 174: 915–924.
12. de Waal Malefyt R., Abrams I., Bennett B., Figdor CG., and de Vries IE.: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. I Exp Med 1991; 174: 1209–1220.
13. Ding L., Linsley PS., Huang L-Y., Germain RN., and Shevach EM.: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. I Immunol 1993; 151: 1224–1234.
14. te Velde AA., de Waal Malefyt R., Huijbens RJ., de Vries JE., and Figdor CG.: IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol 1992; 149: 40484052.
15. Sironi M., Munoz C., Pollicino T., Siboni A., Sciacca FL., Bernasconi S., Vecchi A., Colotta F., and Mantovani A.: Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. Eur J Immunol 1993; 23: 2692–2695.
16. Wogensen L., Huang X., and Sarvetnick N.: Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med 1993; 178: 175–185.
17. Hsu DH., Moore KW., and Spits H.: Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity. Int Immunol 1992; 4: 563–569.
18. Rousset F., Garcia E., Defiance T., Perenne C., Vezzio N., Hsu DH., Kastelein R., Moore KW., and Banchereau I.: Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Nati Acad Sei USA 1992; 89: 1890–1893.
19. Banchereau J., de Paoli P., Valle A., Garcia E., and Rousset F.: Longterm human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991; 251: 70–72.
20. Clerici M., Hakim FT., Venzon DJ., Blatt S., Hendrix CW., Wynn TA., and Shearer GM.: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993; 91: 759–765.
21. Clerici M., Wynn TA., Berzofsky JA., Blatt SP., Hendrix CW., Sher A., Coffman RL., and Shearer GM. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with human immunodeficiency virus. J Clin Invest 1994; 93: 768–775.
22. Poli G. and Fauci AS.: Cytokine modulation of HIV expression. Semin Immunol 1993; 5: 165–173.
23. Koyanagi Y., O'Brien WA., Zhao JQ., Golde DW., Gasson JC., and Chen ISY.: Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 1988; 241: 1673–1675.
24. Kazazi F., Mathijs JM., Chang J., Malafiej P., Lopez A., Dowton D., Sorrell TC., Vadas MA., and Cunningham AL. Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. J Gen Virol 1992; 73: 941–949.
25. Novak RM., Holzer TJ., Kennedy MM., Heynen CA., and Dawson G.: The effect of interleukin 4 (BSF-1) on infection of peripheral blood monocyte-derived macrophages with HIV-1. AIDS Res Hum Retroviruses 1990; 6: 973–976.
26. Gendelman HE., Orenstein JM., Martin MA., Ferma C., Mitra R., Phipps T., Wahl LA., Lane HC., Fauci AS., Burke DS., Skillman D., and Meltzer MS. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 1988; 167: 1428–1441.
27. Poli G., Bressler P., Kinter A., Duh E., Timmer WC., Rabson A., Justement JS., Stanley SK., and Fauci AS.: Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 1990; 172: 151–158.
28. Poli G., Orenstein JM., Kinter A., Folks TM., and Fauci AS.: Interferon-α but not AZT suppresses HIV expression in chronically infected cell lines. Science 1989; 244: 575–577.
29. Gendelman HE., Baca LM., Turpin J., Kalter DC., Hansen B., Orenstein JM., Mieffenbach CW., Friedman RM., and Meltzer MS.: Regulation of HIV replication in infected monocytes by IFN-a. J Immunol 1990; 145: 2669–2676.
30. Shirazi Y. and Pitha PM.: Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J Virol 1992; 66: 1321–1328.
31. Vyakarnam A., McKeating J., Meager A., and Beverley PC.: Tumour necrosis factors (Ct,β) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS 1990; 4: 21–27.
32. Poli G., Kinter A., Justement JS., Kehrl JH., Bressler P., Stanley SK., and Fauci AS.: Tumor necrosis factor a function in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Nati Acad Sei USA 1990; 87: 782–785.
33. + model of chronic infection. J Immunol 1993; 150: 625–634.
34. Tadmori W., Mondai D., Tadmori I., and Prakash O.: Transactivation of human immunodeficiency virus type 1 long terminal repeats by cell surface tumor necrosis factor alpha. J Virol 1991; 65: 6425–6429.
35. Markham PD., Salahuddin SZ., Veren K., Orndorff SH., and Gailo RC.: Hydrocortisone and some other hormones enhance the expression of HTLV-III. Int J Cancer 1986; 37: 67–72.
36. Mace K., Due Dodon M., and Gazzolo L.: Restriction of HIV-1 replication in promonocytic cells: A role for IFN-a. Virology 1989; 168: 399405.
37. Weissman D., Poli G., Bousseau A., and Fauci AS.: A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells. Proc Nati Acad Sei USA 1993; 90: 2537–2541.
38. Clouse KA., Cosentino LM., Weih KA., Pyle SW., Robbins PB., Hochstein HD., Natarajan V., and Farrar WL.: The HIV-1 gpl20 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 1991; 147: 2892–2901.
39. Clouse KA., Robbins RB., Fernie B., Ostrove JM., and Fauci AS.: Viral antigen stimulation of the production of human monokines capable of regulating HIV-1 expression. J Immunol 1989; 143: 470–475.
40. Nakajima K., Martinez-Maza O., Hirano T., Breen EC., Nishanian PG., Salazar-Gonzalez JF., Fahey JL., and Kishimoto T.: Induction of IL-6 (B cell stimulatory factor-2/IFN-β2) production by HIV. J Immunol 1989; 142: 531–536.
41. Merrill JE., Koyanagi Y., and Chen ISY.: Interleukin-1 and tumor necrosis factor can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 1989; 63: 44044408.
42. von Briesen H., von Mallinckrodt C., Esser R., Muller S., Becker K., Rubsamen-Waigmann H., and Andreesen R.: Effect of cytokines and lipopolysaccharides on HIV infection of human macrophages. Res Virol 1991; 142: 197–204.
43. Poli G., Kinter AL., Justement JS., Bressler P., Kehrl JH., and Fauci AS.: Transforming growth factor β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. J Exp Med 1991; 173: 589–597.
44. Poli G., Kinter AL., Justement JS., Bressler P., Kehrl JH., and Fauci AS.: Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells. Proc Nati Acad Sei USA 1992; 89: 2689–2693.
45. Schuitemaker H., Kootstra NA., Koppeiman MH., Bruisten SM., Huisman HG., Tersmette M., and Miedema F.: Proliferation dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest 1992; 89: 1154–1160.
46. Lazdins JK., Klimkait T., Woods-Cook K., Walker M., Alteri E., Cox D., Cerletti N., Shipman R., Bilbe G., and McMaster G.: In vitro effect of transforming growth factor-β on progression of HIV-1 infection in primary mononuclear phagocytes. J Immunol 1991; 147: 1201–1207.
47. Montaner LJ., Doyle AG., Collin M., Georges H., Illei P., James W., Minty A., Caput D., Ferrara P., and Gordon S.: Interleukin 13 inhibits human immuno-deficiency virus type 1 production in primary blood-derived human macrophages. J Exp Med 1993; 178: 743–747.